Schedule 13D ownership disclosure
Cartesian Therapeutics Inc
Security class unavailable · CUSIP: 816212302
Event date: 2024-07-02
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 8,833,106
- Percent of class
- 36.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-24-059561
- Form type
- SC 13D
- Filer
- Cartesian Therapeutics, Inc.
- CIK
- CIK 1453687
- Filed
- Jul 05, 2024
- Reporting period
- Jul 02, 2024
- Description
- Schedule 13D beneficial ownership